Literature DB >> 8226850

Phosphorylation of serine 59 of p56lck in activated T cells.

J D Watts1, J S Sanghera, S L Pelech, R Aebersold.   

Abstract

p56lck, a member of the src family of non-receptor protein tyrosine kinases, is expressed almost exclusively in cells of lymphoid origin. Recent evidence has implicated p56lck in a critical role both in T cell development and activation. A variety of T cell stimuli induce a shift in the electrophoretic mobility of p56lck from an apparent molecular mass of 56 kDa (p56lck) to 60 kDa (p60lck). This shift in electrophoretic mobility correlates with an increase in the phosphoserine content of the p60lck. We have shown that both 4 alpha-phorbol 12 beta-myristate acetate and OKT3 treatment of Jurkat cells, as well as 4 alpha-phorbol 12 beta-myristate acetate treatment of 171.CD4 and LSTRA cells, induced phosphorylation of serine-59 on p56lck in vivo, which correlated with the shift to p60lck. We also demonstrated that the same serine residue could be phosphorylated in vitro with mitogen-activated protein kinases and that this event was capable of reducing p56lck activity in vitro. Combined, these data suggest a novel pathway for the in vivo regulation of p56lck activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226850

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways.

Authors:  P S Costello; A E Walters; P J Mee; M Turner; L F Reynolds; A Prisco; N Sarner; R Zamoyska; V L Tybulewicz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

2.  Regulation of expression and function of Lck tyrosine kinase by high cell density.

Authors:  Patricia Ozegbe; Yuti Chernajovsky; Panagiotis S Kabouridis
Journal:  Mol Membr Biol       Date:  2005 Jul-Aug       Impact factor: 2.857

3.  Suppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cells.

Authors:  Ngozi Monu; Alan B Frey
Journal:  Cancer Res       Date:  2007-12-01       Impact factor: 12.701

4.  The catalytic activity of the kinase ZAP-70 mediates basal signaling and negative feedback of the T cell receptor pathway.

Authors:  Hanna Sjölin Goodfellow; Maria P Frushicheva; Qinqin Ji; Arup K Chakraborty; Arthur Salomon; Arthur Weiss; Debra A Cheng; Theresa A Kadlecek; Aaron J Cantor; John Kuriyan
Journal:  Sci Signal       Date:  2015-05-19       Impact factor: 8.192

5.  Modification of Ser59 in the unique N-terminal region of tyrosine kinase p56lck regulates specificity of its Src homology 2 domain.

Authors:  I Joung; T Kim; L A Stolz; G Payne; D G Winkler; C T Walsh; J L Strominger; J Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

Review 6.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

7.  Herpes simplex virus requires VP11/12 to induce phosphorylation of the activation loop tyrosine (Y394) of the Src family kinase Lck in T lymphocytes.

Authors:  Melany J Wagner; James R Smiley
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

8.  Recruitment of calcineurin to the TCR positively regulates T cell activation.

Authors:  Debjani Dutta; Valarie A Barr; Itoro Akpan; Paul R Mittelstadt; Laishram I Singha; Lawrence E Samelson; Jonathan D Ashwell
Journal:  Nat Immunol       Date:  2016-12-12       Impact factor: 25.606

9.  T cell receptor signal initiation induced by low-grade stimulation requires the cooperation of LAT in human T cells.

Authors:  Shen Dong; Béatrice Corre; Konstantina Nika; Sandra Pellegrini; Frédérique Michel
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

10.  Regulation of the Src family kinase Lck by Hsp90 and ubiquitination.

Authors:  Ana Giannini; Marie-José Bijlmakers
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.